KHN: Without proper monitoring, #contaminated #medicine makes patients sicker

By Sydney Lupkin, Kaiser Health News Photos by Heidi de Marco ANN ARBOR, Mich. — Despite the jackhammer-like rhythm of a mechanical ventilator, Alicia Moreno had dozed off in a chair by her 1-year-old’s hospital bed, when a doctor woke her with some bad news: The common stool softener her son, Anderson, was given months … Continue reading KHN: Without proper monitoring, #contaminated #medicine makes patients sicker

Advertisements

From MIT’s Undark: More and More, New Drugs Clear the FDA With ‘Accelerated Approval’

Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers benefit most. September 10, 2018 by Abigail Fagan & Mark Kaufman On June 28, 2011, ten police cars descended upon the headquarters of the Food and Drug Administration. Scores of protesters carrying loudspeakers and donning … Continue reading From MIT’s Undark: More and More, New Drugs Clear the FDA With ‘Accelerated Approval’

Will 21st Century Cures Act benefit hospitals?

First: The Globe is getting some attention for its five-part narrative about a family that helped  start a drug company to keep their son on an experimental cancer treatment. Nicely written narrative with illustrations and audio. We won't give away the ending.  Also, here's what people were saying a year ago about the "21st Century … Continue reading Will 21st Century Cures Act benefit hospitals?

Two Boston meetings look at the role of patient advocates. They offer two very different perspectives.

Pharmaceutical manufacturers often  look to patient advocates for help winning approval for new drugs. Their most recent success in this area was the FDA’s approval of a new drug for Duchenne muscular dystrophy. That decision came despite recommendations against approval from FDA staff. In an editorial, the Boston Globe questioned the FDA’s move while noting … Continue reading Two Boston meetings look at the role of patient advocates. They offer two very different perspectives.

April 26: Boston health news round up

Health writers on both ends of 135 Morrissey Boulevard have been busy -- main Globe newsroom to STAT down the hall:  From Stat;  from the Globe business desk.  Stat shared this story with the print edition of Globe today: Lam, a 22-year-old aspiring doctor, is part of the fast-growing industry of medical scribes working in hospitals … Continue reading April 26: Boston health news round up

Is female Viagra a scam? Boston women’s health group questions drug, supporters

The non-profits pressuring the FDA to approve a drug billed as female Viagra do not quite make up a top ten list or women's health advocacy organizations. This health writer has never heard of most of the groups cited in Sunday's New York Times story. But familiar women's health groups, like Boston's Our Bodies, Ourselves, … Continue reading Is female Viagra a scam? Boston women’s health group questions drug, supporters

Should the FDA approve Vertex’s new cystic fibrosis drug?

The scene at the FDA hearing was familiar. All the  advisory committees have seen it play out again and again. Yesterday, it was the Pulmonary-Allergy Drug committee: The pharma doc with the convincing statement. The weeping patients. The drug likely to cost a couple thousand a month offering a slim  benefit over an existing drugs. … Continue reading Should the FDA approve Vertex’s new cystic fibrosis drug?